Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 18/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3787528 | 0.99 | CPB2 (0.48) | CPB2CA12CA1CA2CA9 | |
| Trifluoroacetic Acid SCHEMBL3782819 | 0.96 | CPB2 (0.41) | CPB2CA12CA1CA2CA9 | |
| Trifluoroacetic Acid SCHEMBL3781605 | 0.96 | CPB2 (0.41) | CPB2CA12CA1CA2CA9 | |
| Trifluoroacetic Acid SCHEMBL3783935 | 0.96 | CPB2 (0.41) | CPB2CA12CA1CA2CA9 | |
| SCHEMBL3783443 | 0.87 | CPB2 (0.34) | CPB2 | |
| Hydrochloric Acid SCHEMBL3773547 | 0.86 | CPB2 (0.33) | CPB2 | |
| Phosphoric Acid SCHEMBL3784307 | 0.82 | CPB2 (0.31) | CPB2 | |
| Trifluoroacetic Acid SCHEMBL3782480 | 0.82 | CPB2 (0.30) | CPB2 | |
| Trifluoroacetic Acid SCHEMBL3776202 | 0.82 | HTR5A (0.31) | CPB2 | |
| SCHEMBL3780433 | 0.81 | CPB2 (0.34) | CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8309341-B2 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | Les Laboratories Server (FR) | 2012-11-13 | — | — | US | disclosed |
| US-20100330064-A1 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330064-A1 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | CYP2B6, CYP2A6, MC5R | CPB2 1603/4885CA12 858/4885CA1 2065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.